ask="31.25"
ask_size="100"
average_daily_volume="672397"
bid="26.65"
bid_size="100"
book_value="10.14"
change="+0.05"
change_from_200_day_moving_average="17.43"
change_from_50_day_moving_average="11.93"
change_from_52_week_high="-1.38"
change_From_52_week_low="21.93"
change_in_percent="+0.16%"
close="31.33"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.33"
ebitda="-75.90M"
eps_estimate_current_year="-5.80"
eps_estimate_next_quarter="-1.46"
eps_estimate_next_year="-4.94"
ex_dividend_date="N/A"
float_shares="13256000"
high="32.71"
high_52_weeks="32.71"
last_trade_date="3/7/2017"
last_trade_price="31.33"
last_trade_size="11159"
last_trade_time="4:00pm"
low="30.59"
low_52_weeks="9.40"
market_capitalization="706.65M"
moving_average_200_day="13.90"
moving_average_50_day="19.40"
name="Esperion Therapeutics
Inc."
notes="N/A"
one_year_target_price="27.70"
open="30.73"
pe_ratio="N/A"
peg_ratio="0.95"
percent_change_from_200_day_moving_average="+125.32%"
percent_change_from_50_day_moving_average="+61.49%"
percent_change_from_52_week_high="-4.22%"
percent_change_from_52_week_low="+233.30%"
previous_close="31.28"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.09"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="22555000"
short_ratio="5.08"
stock_exchange="NGM"
symbol="ESPR"
volume="786242"
weeks_range_52="9.40 - 32.71"
